UGI / HPB NSSG Clinical Guidelines Contents

The combination of a dilated pancreatic duct and common bile duct on any imaging in the absence of a visible mass. ... Up to 15 % of such lesions may not be pancreatic adenocarcinomas and therefore may have a better prognosis and may be amenable to alternative chemotherapy. Participation in clinical trials requires histological proof of diagnosis. ................
................